Arbutus Biopharma Corp (ABUS)
2.775
-0.06
(-1.94%)
USD |
NASDAQ |
May 08, 14:30
Arbutus Biopharma Accounts Payable (Quarterly): 3.743M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.743M |
December 31, 2023 | 3.223M |
September 30, 2023 | 2.26M |
June 30, 2023 | 1.044M |
March 31, 2023 | 2.455M |
December 31, 2022 | 3.52M |
September 30, 2022 | 0.872M |
June 30, 2022 | 0.00 |
March 31, 2022 | 1.194M |
December 31, 2021 | 3.174M |
September 30, 2021 | 1.042M |
June 30, 2021 | 2.063M |
March 31, 2021 | 0.355M |
December 31, 2020 | 2.994M |
September 30, 2020 | 0.852M |
June 30, 2020 | 1.182M |
March 31, 2020 | 0.519M |
December 31, 2019 | 2.398M |
September 30, 2019 | 1.40M |
June 30, 2019 | 0.685M |
March 31, 2019 | 2.344M |
December 31, 2018 | 3.192M |
September 30, 2018 | 3.075M |
June 30, 2018 | 3.208M |
March 31, 2018 | 0.943M |
Date | Value |
---|---|
December 31, 2017 | 1.987M |
September 30, 2017 | 2.291M |
June 30, 2017 | 3.368M |
March 31, 2017 | 1.614M |
December 31, 2016 | 3.215M |
September 30, 2016 | 2.071M |
June 30, 2016 | 1.744M |
March 31, 2016 | 3.993M |
December 31, 2015 | 2.61M |
September 30, 2015 | 2.898M |
June 30, 2015 | 2.802M |
March 31, 2015 | 7.242M |
December 31, 2014 | 2.044M |
September 30, 2014 | 3.389M |
June 30, 2014 | 1.778M |
March 31, 2014 | 2.141M |
December 31, 2013 | 1.217M |
September 30, 2013 | 0.7768M |
June 30, 2013 | 1.475M |
March 31, 2013 | 1.267M |
December 31, 2012 | 0.8058M |
September 30, 2012 | 1.270M |
June 30, 2012 | 1.178M |
March 31, 2012 | 1.288M |
December 31, 2011 | 1.258M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2022
3.743M
Maximum
Mar 2024
1.749M
Average
1.297M
Median
Accounts Payable (Quarterly) Benchmarks
Moderna Inc | 183.00M |
Pacira BioSciences Inc | 15.70M |
Chimerix Inc | 3.823M |
Karyopharm Therapeutics Inc | 3.123M |
Corvus Pharmaceuticals Inc | 1.525M |